Since the beginning of the COVID-19 epidemic, the European cystic fibrosis society (ECFS) has decided to launch a special ECFS-COVID-19 program to collect information on the of COVID-19 characteristics in the patients with cystic fibrosis (CF) The results of the program should help timely and efficiently provide the patients with CF with the necessary care Initially, it was assumed that COVID-19 would be severe in CF patients The aim Тo assess the prevalence and characteristics of COVID-19 in patients with cystic fibrosis (CF) in the Russian Federation (RF) Methods 6 cases (4 children and 2 adults) of COVID-19 in Russian CF patients were analyzed Results There are 405,843 infected with SARS-CoV-2 in Russia, the incidence of coronavirus infection in Russia was 1 4 cases per 1 thousand people According to the Ministry of Health of the RF, as of December 2019, there were 3,931 patients with CF (2,823 children and 1,108 adults) The incidence of COVID-19 was 1 5 per 1000 patients with CF (1 4: 1,000 for children and 1 8: 1,000 for adults) The incidence was not higher than in the General population The diagnosis of COVID-19 was confirmed in 4 boys and 2 women, 3 of the patients were infected with Pseudomonas aeruginosa and 2 – with Achromobacter spp Mild disease was seen in 5 patients including all the children Pneumonia was registered in 3 patients One child with COVID-19 had abdominal syndrome 2 patients – 1 adult and 1 child – needed in-patient care Additional antibiotics were given to 4 patients, 2 of them received i/v antibiotics One adult patient was on the lung transplantation waiting list This woman had long-term oxygen therapy and BiPAP noninvasive respiratory support before the infection with SARS-CoV-2, FEV1 was 24 %pred Conclusion Despite the fact that patients with CF are at risk of severe COVID-19, to date, in the described cases, COVID-19 infection has not led to a significant deterioration of the symptoms of CF Not a single fatal outcome in Russian patients with CF has been recorded © 2020 Medical Education All rights reserved
COVID-19 in cystic fibrosis patients